Drimva

Novartis

Manager, Cardiovascular Priority Accounts – Houston

$146K–$270K

Field Non-Sales (USA) +1 · Manager · Full-time · Posted Aug 5, 2026

Location
Field Non-Sales (USA)
Houston (Texas)
Experience
5+ years in specified industries, including 2+ years in specialty buy-and-bill; 2+ years managing complex accounts.
Education
Bachelor’s degree from a 4-year college or university required.
Visa sponsorship
Company will not sponsor visas for this position.

About the job

Drives appropriate use and product pull-through for cardiovascular brands across assigned priority accounts and healthcare systems through strategic account planning, customer engagement, and cross-functional execution.

What you'll do

  • Develop and implement strategic business plans for priority accounts and affiliated healthcare systems to support formulary adoption and product utilization.
  • Build relationships with administrative, clinical, operational, and financial stakeholders; assess customer needs and coordinate account strategies.
  • Lead cross-functional initiatives, presentations, and workflow enablement, including identifying injection locations and integrating workflows with EMR.

What they ask for

  • Bachelor’s degree from a 4-year college or university.
  • 5+ years’ experience in pharmaceutical, biotech, healthcare, or similarly structured industries; 2+ years’ experience in specialty buy-and-bill.
  • 2+ years’ experience managing complex accounts, including major academic centers and hospitals.
  • Reside within the territory or within a reasonable daily commuting distance of 50 miles from its border; travel 60–80%; valid, unrestricted driver’s license.

Nice to have

  • Experience calling on assigned cardiovascular accounts.
  • Experience in two different cross-functional roles or areas, such as Marketing, Medical, Market Access and Reimbursement, or Sales Leadership.

Pay

$145,600 and $270,400 per year (base salary); $145,600.00 - $270,400.00 (base salary)

Tools

EMR

Model-written summary · the original posting is authoritative

First seen Oct 28, 2026 · Last verified Nov 5, 2026 (UTC)